Skip to content

Protein Modifications and Sepsis Research

Protein Modifications and Sepsis Research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129240
Enrollment
Unknown
Registered
2026-08-01
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sepsis group:None
Healthy control group:None

Sponsors

The Second Hospital,University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the sepsis group were as follows: (1) meeting the Sepsis-3 international diagnostic criteria; (2) aged 18–75 years; (3) having complete clinical records and laboratory data; (4) being able to cooperate with peripheral blood sampling; (5) providing written informed consent. 2. For the healthy control group, the criteria were: (1) undergoing routine health check-ups during the same period; (2) matched with the sepsis group for age and sex; (3) having no acute or chronic infections, autoimmune diseases, malignancies, or severe chronic disorders of the heart, liver, or kidneys; (4) not taking any immunomodulatory agents within the previous 3 months; (5) voluntarily participating and signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Age 75 years; 2. Presence of malignant tumors, autoimmune diseases, hematologic disorders, end-stage organ failure, or other severe comorbidities; 3. Long-term use of glucocorticoids, immunosuppressants, or other medications affecting immune function; 4. Pregnancy or lactation; 5. Incomplete clinical data, inability to cooperate with sample collection, or unwillingness to participate in the study.

Design outcomes

Primary

MeasureTime frame
Expression levels of molecular proteins related to protein translation;

Secondary

MeasureTime frame
Severity of illness in patients with sepsis;28-day clinical prognosis;

Countries

China

Contacts

Public ContactBaiqi Wang

The Second Hospital,University of South China

wangbaiqi99@126.com+86 734 8899695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026